XML 14 R2.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED BALANCE SHEETS - USD ($)
Feb. 28, 2025
Aug. 31, 2024
Current    
Cash $ 6,468,934 $ 6,499,885
Marketable securities 73,915 55,807
Accounts receivable 331,166 154,477
Prepaid expenses and other current assets 850,387 1,187,817
Total Current Assets 7,724,402 7,897,986
Non-current assets, net    
Long-term receivables 64,014 63,575
Right of use assets 121,084 134,843
Intellectual property, net 506,180 516,676
Property & equipment, net 261,890 254,709
Total Non-current Assets 953,168 969,803
TOTAL ASSETS 8,677,570 8,867,789
Current Liabilities    
Accounts payable and accrued liabilities 1,793,079 1,066,409
Deferred revenue 0 4,963
Lease liability, current 29,337 28,047
Total Current Liabilities 1,822,416 1,099,419
Lease liabilities - non-current 94,386 109,319
TOTAL LIABILITIES 1,916,802 1,208,738
Stockholders' Equity    
Share Capital Authorized: 220,000,000 common voting shares with a par value of $0.001 per share Common shares issued and outstanding: 17,559,179 and 17,449,179, respectively, at February 28, 2025, and 15,810,205 at August 31, 2024 17,559 15,810
Additional paid-in capital 64,221,176 59,599,178
Accumulated Deficit (56,975,683) (51,558,772)
Accumulated other comprehensive loss (118,246) (19,816)
Equity attributable to shareholders of Lexaria 7,144,806 8,036,400
Non-controlling Interest (384,038) (377,349)
Total Stockholders' Equity 6,760,768 7,659,051
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 8,677,570 $ 8,867,789